The neurodegeneration that ultimately leads to Alzheimer's disease begins one or more decades before cognitive impairment is evident. As eventual therapies are ultimately achieved, it is therefore equally important to develop methods capable of detecting the molecular events responsible for neuronal death. We are very interested in exploring the potential of a novel compound to allow the early detection of Alzheimer's pathology by MRI.